The intelligence layer
for clinical trials.
Our AI agents sit between every system a site touches (source docs, eSource, EDC, sponsor portals), transferring data, resolving discrepancies before they become queries, and turning every study into operational intelligence that compounds over time.
The infrastructure hasn't
kept pace with the science.
a drug to market
discovery to approval
late-stage trial
and accelerating
Four agents.
One connected system.
Each agent handles a discrete workflow at the site level. Together, they close the loop between protocol, source documentation, and the EDC.
Protocol → CRF Reconciliation
Continuously reconciles protocol amendments against case report forms, surfacing discrepancies before they become audit findings.
eSource Document Generation
Generates structured eSource documents from clinical observations, maintaining regulatory-grade provenance from point of care.
eSource → EDC Data Transfer
Transfers verified source data into the EDC with full audit trail, eliminating manual transcription and its downstream query burden.
Autonomous Trial Operations
Continuously monitors the full site workflow, agentically resolves operational bottlenecks in real time, and routes decisions that require human judgment for coordinator approval before execution.
Every action compounds
into proprietary context.
The more the system runs, the more capable it becomes.
Agentic operating system
for clinical trials.
The future of clinical trials is a system that actually understands and interacts with every system and every data point it touches. Connective tissue across the full stack. Protocols that propagate themselves. Queries that resolve before they're filed. Intelligence that compounds with every study.
Intake AI's mission is to materially change how fast, efficiently, and safely drugs are developed and brought to market — for every patient waiting on the other side.
Building at the
frontier.
